The Latest Breaking News from MedTech

With a recession expected this year due to the Fed’s hawkish stance, investors could look to buy fundamentally strong dividend-paying stocks Johnson & Johnson (JNJ), Kroger (KR), and Bluegreen Vacations Holding (BVH). Keep reading….

With concerns of a recession weighing heavily on investors’ decisions, well-reputed companies paying stable dividends could be smart investments for investors over 50. Therefore, it might be wise for investors to buy fundamentally strong stocks like Johnson & Johnson (JNJ) and Coca-Cola (KO). Read more….

With interest rates expected to increase throughout this year, the stock market will likely remain under pressure. Amid the anticipated volatility in the stock market this year, investors may consider investing in stable and dividend-paying stocks Johnson & Johnson (JNJ), The Procter & Gamble Company (PG), and AptarGroup (ATR) to…

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

Along with an interest rate hike of 50 bps at the FOMC meeting last week, the Fed officials signaled to continue raising rates through next year, with no expectations to cut rates until 2024. The Fed’s hawkish stance and rising recessionary fears have dampened investor sentiment lately. Given the backdrop,…

Yesterday’s retail sales report showed that consumers pulled back on spending last month, raising fears of a recession. Moreover, the Fed signaled to keep raising rates more through the following year. Given an uncertain market backdrop, investors should buy fundamentally sound and dividend-paying stocks Johnson (JNJ), Coca-Cola (KO), and Cardinal…

Persistently high inflation and the Federal Reserve’s hawkish stance to handle it has resulted in significant market volatility this year. Moreover, experts amplified their warnings of a recession next year. Given the uncertain market backdrop, it could be wise to invest in fundamentally sound and resilient stocks, Johnson & Johnson…

The Fed’s aggressive monetary policy stance created immense recession fear until the inflation showed signs of cooling down in October, and the policymakers hinted at a slower pace of rate hikes. Amid such an uncertain macroeconomic scenario, investors could consider buying safe-haven stocks Johnson & Johnson (JNJ), The Coca-Cola Company…

The healthcare industry is expected to witness significant growth in the foreseeable future, driven by rising health awareness, an aging population, and increasing chronic diseases worldwide. Furthermore, the healthcare industry is known to perform steadily regardless of economic conditions because of the inelastic demand for healthcare products and services. Therefore,…

Despite the October inflation report showing a slowdown in the price increases, the U.S. economy is still surrounded by deep uncertainty. Moreover, the IMF has warned of further challenges ahead. Therefore, quality stocks Johnson & Johnson (JNJ) and Coca-Cola (KO), which have a solid dividend-paying record, could be ideal additions…

"The addition of Abiomed is an important step in our vision for the new Johnson & Johnson focused on Pharmaceutical and MedTech," said CEO Joaquin Duato.